Thomas F. Baumert

903 total citations
12 papers, 706 citations indexed

About

Thomas F. Baumert is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas F. Baumert has authored 12 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 6 papers in Epidemiology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas F. Baumert's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Thomas F. Baumert is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Thomas F. Baumert collaborates with scholars based in France, United States and Germany. Thomas F. Baumert's co-authors include Raymond Chung, Luke W. Meredith, Timothy L. Tellinghuisen, Ke Hu, Sophie Krieger, Jane A. McKeating, Andrew J. Syder, Joe Grove, Peter Balfe and Flossie Wong‐Staal and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Thomas F. Baumert

12 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas F. Baumert France 10 511 454 117 94 85 12 706
Patrick Maillard France 13 401 0.8× 368 0.8× 113 1.0× 185 2.0× 72 0.8× 22 665
Daisuke Akazawa Japan 16 658 1.3× 522 1.1× 138 1.2× 210 2.2× 151 1.8× 25 906
Lionello Ruggeri Italy 8 409 0.8× 363 0.8× 89 0.8× 106 1.1× 63 0.7× 10 626
Ronda K. Sapp United States 7 480 0.9× 405 0.9× 82 0.7× 75 0.8× 74 0.9× 8 574
Doris Quinkert United Kingdom 8 308 0.6× 258 0.6× 87 0.7× 150 1.6× 39 0.5× 16 757
Anna Shavinskaya France 3 692 1.4× 554 1.2× 77 0.7× 327 3.5× 131 1.5× 3 1.0k
Kathrin Hueging Germany 10 398 0.8× 318 0.7× 38 0.3× 80 0.9× 68 0.8× 10 511
Noha G. Bader El Din Egypt 15 364 0.7× 350 0.8× 81 0.7× 167 1.8× 62 0.7× 47 614
Akihiro Furusaka Japan 11 852 1.7× 770 1.7× 93 0.8× 314 3.3× 156 1.8× 16 1.1k
Jianwen He China 5 315 0.6× 227 0.5× 37 0.3× 144 1.5× 37 0.4× 7 437

Countries citing papers authored by Thomas F. Baumert

Since Specialization
Citations

This map shows the geographic impact of Thomas F. Baumert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Baumert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Baumert more than expected).

Fields of papers citing papers by Thomas F. Baumert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F. Baumert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Baumert. The network helps show where Thomas F. Baumert may publish in the future.

Co-authorship network of co-authors of Thomas F. Baumert

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Baumert. A scholar is included among the top collaborators of Thomas F. Baumert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Baumert. Thomas F. Baumert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wrensch, Florian, et al.. (2018). Mapping Determinants of Virus Neutralization and Viral Escape for Rational Design of a Hepatitis C Virus Vaccine. Frontiers in Immunology. 9. 1194–1194. 32 indexed citations
2.
Colpitts, Che C., et al.. (2015). High-throughput approaches to unravel hepatitis C virus-host interactions. Virus Research. 218. 18–24. 9 indexed citations
3.
Mailly, Laurent, Mirjam B. Zeisel, & Thomas F. Baumert. (2015). Enfermé dehors. médecine/sciences. 31(12). 1075–1077. 2 indexed citations
4.
Duong, François H.T., Gaia Trincucci, Tujana Boldanova, et al.. (2014). IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies. The Journal of Experimental Medicine. 211(5). 857–868. 52 indexed citations
5.
Chung, Raymond & Thomas F. Baumert. (2014). Curing Chronic Hepatitis C — The Arc of a Medical Triumph. New England Journal of Medicine. 370(17). 1576–1578. 169 indexed citations
6.
Ploen, Daniela, Mohamed Lamine Hafirassou, Kiyoshi Himmelsbach, et al.. (2013). TIP47 plays a crucial role in the life cycle of hepatitis C virus. Journal of Hepatology. 58(6). 1081–1088. 59 indexed citations
7.
Potel, J, Patrice Rassam, Elisabeth Werkmeister, et al.. (2013). EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry. Cellular Microbiology. 15(7). 1234–1252. 33 indexed citations
8.
Florentin, Jonathan, Christine Thumann, Françoise Gondois‐Rey, et al.. (2012). HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. Blood. 120(23). 4544–4551. 47 indexed citations
9.
Zahid, Muhammad, Marine Turek, Fei Xiao, et al.. (2012). The Postbinding Activity of Scavenger Receptor Class B Type I Mediates Initiation of Hepatitis C Virus Infection and Viral Dissemination. Hepatology. 57(2). 492–504. 60 indexed citations
10.
Fafi‐Kremer, Samira, Catherine Fauvelle, Daniel J. Felmlee, et al.. (2012). Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection. Viruses. 4(10). 2016–2030. 23 indexed citations
11.
Robinet, Éric & Thomas F. Baumert. (2011). A first step towards a mouse model for hepatitis C virus infection containing a human immune system. Journal of Hepatology. 55(3). 718–720. 20 indexed citations
12.
Brimacombe, Claire L., Joe Grove, Luke W. Meredith, et al.. (2010). Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission. Journal of Virology. 85(1). 596–605. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026